ICM
Indaba Capital Management’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,363,064
| Closed | -$20M | – | 9 |
|
|
2024
Q1 | $20M | Sell |
7,363,064
-83,165
| -1% | -$225K | 13.03% | 5 |
|
|
2023
Q4 | $16.5M | Hold |
7,446,229
| – | – | 9.45% | 5 |
|
|
2023
Q3 | $21.6M | Hold |
7,446,229
| – | – | 6.36% | 7 |
|
|
2023
Q2 | $14.4M | Hold |
7,446,229
| – | – | 4.86% | 7 |
|
|
2023
Q1 | $14.5M | Hold |
7,446,229
| – | – | 4.49% | 9 |
|
|
2022
Q4 | $8.71M | Hold |
7,446,229
| – | – | 1.69% | 19 |
|
|
2022
Q3 | $8.19M | Hold |
7,446,229
| – | – | 1.26% | 23 |
|
|
2022
Q2 | $11.9M | Hold |
7,446,229
| – | – | 1.57% | 23 |
|
|
2022
Q1 | $26.7M | Hold |
7,446,229
| – | – | 3.03% | 14 |
|
|
2021
Q4 | $29.2M | Hold |
7,446,229
| – | – | 3.13% | 15 |
|
|
2021
Q3 | $49.1M | Hold |
7,446,229
| – | – | 5.2% | 5 |
|
|
2021
Q2 | $45.9M | Hold |
7,446,229
| – | – | 4.95% | 7 |
|
|
2021
Q1 | $33.7M | Buy |
7,446,229
+1,915,629
| +35% | +$8.66M | 4.23% | 8 |
|
|
2020
Q4 | $33.2M | Buy |
5,530,600
+1,566,848
| +40% | +$9.4M | 5.85% | 8 |
|
|
2020
Q3 | $29.5M | Hold |
3,963,752
| – | – | 9.36% | 4 |
|
|
2020
Q2 | $15.9M | Buy |
3,963,752
+143,786
| +4% | +$577K | 6.02% | 7 |
|
|
2020
Q1 | $9.7M | Buy |
3,819,966
+496,978
| +15% | +$1.26M | 5.23% | 9 |
|
|
2019
Q4 | $11.6M | Buy |
3,322,988
+601,700
| +22% | +$2.09M | 4.68% | 8 |
|
|
2019
Q3 | $12.6M | Buy |
+2,721,288
| New | +$12.6M | 2.95% | 14 |
|
|
2019
Q1 | – | Sell |
-400,000
| Closed | -$3.45M | – | 25 |
|
|
2018
Q4 | $3.45M | Buy |
+400,000
| New | +$3.45M | 0.76% | 24 |
|